Mrs. Kayla E Martin, PT, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: Marshfield Medical Center Neillsville, N3708 River Avenue, Neillsville, WI 54456 Phone: 715-819-8274 Fax: 715-743-6242 |
Mark Edward Reinhardt, PT Physical Therapist Medicare: Medicare Enrolled Practice Location: N3708 River Ave, Neillsville, WI 54456 Phone: 715-743-3101 Fax: 715-743-6245 |
Taylor M Koenig, PT, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 216 Sunset Pl, Neillsville, WI 54456 Phone: 715-743-8440 |
Taryn Loos Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 216 Sunset Pl, Neillsville, WI 54456 Phone: 715-743-6242 |
Sheri L Hayes, PT Physical Therapist Medicare: Medicare Enrolled Practice Location: N3708 River Avenue, Neillsville, WI 54456 Phone: 715-743-3101 |
Dorene Joy Binder, PT Physical Therapist Medicare: Medicare Enrolled Practice Location: N3708 River Ave, Neillsville, WI 54456 Phone: 715-255-8551 Fax: 715-652-3473 |
News Archive
Cellectis, a clinical-stage biopharmaceutical company focused on developing immunotherapies based on gene-edited CAR T-cells (UCART), today announced the grant by the European Patent Office of patent No. EP3004337 for the invention of using RNA-guided endonucleases, such as Cas9 or Cpf1 for the genetic engineering of T-cells.
Roche Molecular Systems, Inc. announced today that preliminary data from its ATHENA (Addressing THE Need for Advanced HPV Diagnostics) trial support the importance of screening for human papillomavirus (HPV) genotypes that put women at highest risk for developing cervical cancer. ATHENA is a prospective, double-blind, multi-centered, 47,000-patient, U.S.-registration trial designed to demonstrate the effectiveness of HPV detection as part of a cervical cancer screening program.
Researchers from the University of Minnesota College of Pharmacy have provided the first evidence-based data on changes in drug metabolism in obese children as compared to healthy weight children.
Volcano Corporation announced today it received both 510(k) clearance and CE Mark approval for its PrimeWire PRESTIGE Pressure Guide Wire for use with patients who have both single-vessel and multi-vessel disease. This next generation pressure wire is compatible with Volcano's full suite of integrated multi-modality consoles and stand-alone physiology systems as well as various hemodynamic monitoring systems.
› Verified 5 days ago